Reports are emerging about the oligonucleotide therapeutics market, with some outlets focusing on related contract development and manufacturing organization (cdmo) markets. The market size and growth of oligonucleotide therapeutics and related fields, such as peptide and nucleic acid therapeutics, are being reported on, with forecasts extending to 2029 and 2033. The specific details and projections of these reports vary, with multiple markets and industries being covered.